Navigator Medicines Secures $100M Series A Financing and In-Licenses NAV-240
Key Highlights Navigator Medicines closes $100M Series A financing co-led by RA Capital Management and Forbion. In-licenses NAV-240 and…
Browsing Tag
Forbion
7 posts
AIRNA Closes $60M Series A Round to Advance RNA Editing Therapeutics
Key Highlights AIRNA secures $60M in oversubscribed Series A financing. Funding led by Forbion with key investments from…
Beacon Therapeutics Secures $170 Million in Series B Funding
Key Highlights $170 million raised in Series B funding led by Forbion. Funds to support AGTC-501 clinical trials for X-Linked Retinitis Pigmentosa (XLRP).…
Marea Therapeutics Launches with $190 Million to Transform Cardiometabolic Disease Treatment
Key Highlights $190 million in Series A and B financings led by top investors. MAR001 targets ANGPTL4 to…
Progentos Therapeutics Secures $65 Million Series A to Advance MS Treatment
Key Highlights Progentos Therapeutics launched and closed $65 million Series A round. Funding supports MS program through human proof…
Mariana Oncology Acquired by Novartis for $1.75 Billion
Key Highlights $1 billion upfront, with up to $750 million in potential milestones for Mariana Oncology’s acquisition. Mariana Oncology’s…
Capstan Therapeutics Secures $175M in Series B
Key Highlights $175M Series B financing led by RA Capital Management with broad investor participation. Funds to advance CPTX2309, Capstan’s…